Join BOPA
Back to news articles

Publication update – AML regimen specific consent forms

By BOPA on 21st May 2021

National Systemic Anti-Cancer Therapy (SACT) consent forms publication update

I am pleased to inform you that the Acute Myeloid Leukaemia (AML) national regimen specific consent forms are now available and published on the Cancer Research UK website.

 

Please visit www.cruk.org/sact_consent to view and download the forms.

Please do not hesitate to contact Alia Nizam (Oncology Pharmacist – CRUK information lead, Guy’s and St. Thomas’ NHS Foundation Trust) if you have any queries.

Alia Nizam ([email protected])

21th March 2021

Latest News

By BOPA Committee on behalf of UK SACT board on 23rd May 2025

UK SACT Board publication: Guidance on the contents of a SACT protocol

  Dear Colleague,   Please find a link to the updated publication, “Guidance for the Content of SACT Protocol,” available here: https://www.uksactboard.org/publications.   This document has been developed to support…

Read article
By BOPA Executive Committee on 21st May 2025

Vision and Common Purpose for UK Pharmacy Professional Leadership – UKPPL Board and BOPA

BOPA is an Ex-Officio Member (Specialist Pharmacy Group) of the UKPPL Board with our Chair, Joseph Williams, representing BOPA members and all Cancer Pharmacy Professionals.  Through the Board’s work, closer…

Read article
By BOPA Executive Committee on 14th May 2025

BOPA Fellowship Nominations are NOW OPEN!

We are pleased to announce that BOPA Fellowship Nominations have now opened for 2025.  There is a clear nomination and selection process including specific criteria for assessing the nominated individuals.…

Read article
By BOPA Committee on 13th May 2025

#BOPA2025 at ICC Belfast – Draft Agenda now available

The 28th British Oncology Pharmacy Association (BOPA) Annual Conference, 3-5 October 2025, ICC Belfast The Draft Agenda is available to view here: https://www.bopa.org.uk/resources/the-28th-bopa-annual-conference-2025-draft-agenda/ The conference will include an exciting variety…

Read article